CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
about
Imaging activity in astrocytes and neurons with genetically encoded calcium indicators following in utero electroporation.Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damageThe Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter.
P2860
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@en
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@nl
type
label
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@en
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@nl
prefLabel
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@en
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@nl
P2093
P2860
P1433
P1476
CGX-1007 prevents excitotoxic cell death via actions at multiple types of NMDA receptors.
@en
P2093
Alexandre Dalpé-Charron
Anitha B Alex
Christopher A Reilly
Gerald W Saunders
Karen S Wilcox
P2860
P304
P356
10.1016/J.NEURO.2011.03.002
P577
2011-03-17T00:00:00Z